Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dicker

Showing results (331-340 of 375) with videos related to

Pageof 38
Sort By:
Cancer|October 4, 2025
Validation of the Functional Assessment of Cancer Therapy - Immune Checkpoint Modulator 17-Item Symptom Index (FACT-ICM-17) to facilitate implementation in research and clinical careLisa M Gudenkauf, Danielle B Tometich, Aasha I Hoogland, et al.
JCO Clinical Cancer Informatics|August 7, 2020
Provider Engagement in Radiation Oncology Data Science: Workshop ReportAnshu K Jain, Sanjay Aneja, Clifton D Fuller, et al.
BJU International|January 14, 2012
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study GroupPeter Grimm, Ignace Billiet, David Bostwick, et al.
Prostate Cancer and Prostatic Diseases|May 4, 2016
Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic riskA E Ross, R B Den, K Yousefi, et al.
Cancer Research Communications|September 20, 2023
The Inherited KRAS-variant as a Biomarker of Cetuximab Response in NSCLCJoanne B Weidhaas, Chen Hu, Ritsuko Komaki, et al.
JAMA Oncology|January 10, 2016
Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate CancerJoseph R Evans, Shuang G Zhao, S Laura Chang, et al.
Cancer Research|December 8, 2016
RB Loss Promotes Prostate Cancer MetastasisChellappagounder Thangavel, Ettickan Boopathi, Yi Liu, et al.
Cancer Discovery|September 21, 2012
Dual roles of PARP-1 promote cancer growth and progressionMatthew J Schiewer, Jonathan F Goodwin, Sumin Han, et al.
Frontiers in Immunology|March 15, 2024
Biological insights from plasma proteomics of non-small cell lung cancer patients treated with immunotherapyJair Bar, Raya Leibowitz, Niels Reinmuth, et al.
The Lancet. Oncology|October 17, 2016
Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysisShuang G Zhao, S Laura Chang, Daniel E Spratt, et al.
Pageof 38

Showing results (331-340 of 375) with videos related to

Sort By:
Pageof 38
Cancer|October 4, 2025
Validation of the Functional Assessment of Cancer Therapy - Immune Checkpoint Modulator 17-Item Symptom Index (FACT-ICM-17) to facilitate implementation in research and clinical careLisa M Gudenkauf, Danielle B Tometich, Aasha I Hoogland, et al.
JCO Clinical Cancer Informatics|August 7, 2020
Provider Engagement in Radiation Oncology Data Science: Workshop ReportAnshu K Jain, Sanjay Aneja, Clifton D Fuller, et al.
BJU International|January 14, 2012
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study GroupPeter Grimm, Ignace Billiet, David Bostwick, et al.
Prostate Cancer and Prostatic Diseases|May 4, 2016
Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic riskA E Ross, R B Den, K Yousefi, et al.
Cancer Research Communications|September 20, 2023
The Inherited KRAS-variant as a Biomarker of Cetuximab Response in NSCLCJoanne B Weidhaas, Chen Hu, Ritsuko Komaki, et al.
JAMA Oncology|January 10, 2016
Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate CancerJoseph R Evans, Shuang G Zhao, S Laura Chang, et al.
Cancer Research|December 8, 2016
RB Loss Promotes Prostate Cancer MetastasisChellappagounder Thangavel, Ettickan Boopathi, Yi Liu, et al.
Cancer Discovery|September 21, 2012
Dual roles of PARP-1 promote cancer growth and progressionMatthew J Schiewer, Jonathan F Goodwin, Sumin Han, et al.
Frontiers in Immunology|March 15, 2024
Biological insights from plasma proteomics of non-small cell lung cancer patients treated with immunotherapyJair Bar, Raya Leibowitz, Niels Reinmuth, et al.
The Lancet. Oncology|October 17, 2016
Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysisShuang G Zhao, S Laura Chang, Daniel E Spratt, et al.
Pageof 38